Table 3.

Adjusted odds of immunologic success for patient, disease, and treatment-related predictors

	Adjusted OR for immunologic success‡ [95% CI]	p-value
CB care [n = 178] (vs. HB [n=237])	0.76 [0.47–1.21]
Patient characteristics
Age ≥ 50 years	1.02 [0.60–1.73]	0.96
Male gender	0.97 [0.60–1.57]	0.90
Ethnicity
African-American	1.43 [0.54–3.81]	0.47
Latino	0.99 [0.36–2.70]	0.98
HIV risk factor
IDU	0.66 [0.34–1.27]	0.21
Current illicit substance use	0.79 [0.48–1.31]	0.36
≥ 95% cART adherence	5.30 [3.20–8.77]	< 0.01
Disease characteristics
HIV diagnosis ≥ 5 years	0.74 [0.39–1.42]	0.37
Pre-treatment CD4 > 200 cells/mm3	0.87 [0.52–1.44]	0.58
Pre-treatment VL > 100k copies/mL	1.67 [0.96–2.91]	0.07
Treatment characteristics
Current/ever antiretroviral use	0.63 [0.31–1.25]	0.19
NNRTI-based regimen	0.96 [0.56–1.63]	0.87
Visit frequency (vs. 1–3 visits/year)
4–5 visits/year	1.68 [0.84–3.34]	0.14
≥ 6 visits/year	2.42 [1.22–4.81]	0.01

Note:

^‡including adjustment for propensity score

[abbreviations: CB = community-based, HB = hospital-based]